Northland Capmk Predicts Astera Labs Q1 Earnings

Astera Labs, Inc. (NASDAQ:ALABFree Report) – Northland Capmk issued their Q1 2026 earnings per share (EPS) estimates for Astera Labs in a report released on Tuesday, February 11th. Northland Capmk analyst G. Richard forecasts that the company will earn $0.09 per share for the quarter. Northland Capmk currently has a “Strong-Buy” rating on the stock. The consensus estimate for Astera Labs’ current full-year earnings is ($0.45) per share. Northland Capmk also issued estimates for Astera Labs’ Q2 2026 earnings at $0.13 EPS, Q3 2026 earnings at $0.17 EPS and Q4 2026 earnings at $0.22 EPS.

Astera Labs (NASDAQ:ALABGet Free Report) last released its earnings results on Monday, February 10th. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.26 by ($0.16). Astera Labs had a negative return on equity of 15.57% and a negative net margin of 30.69%.

ALAB has been the subject of a number of other reports. Northland Securities raised Astera Labs from a “market perform” rating to an “outperform” rating and set a $120.00 target price for the company in a research note on Tuesday, January 28th. Morgan Stanley reduced their target price on Astera Labs from $142.00 to $114.00 and set an “equal weight” rating for the company in a report on Tuesday, January 28th. Needham & Company LLC reaffirmed a “buy” rating and set a $140.00 price target on shares of Astera Labs in a research note on Tuesday. Craig Hallum raised their price objective on shares of Astera Labs from $105.00 to $125.00 and gave the company a “buy” rating in a research note on Tuesday. Finally, Deutsche Bank Aktiengesellschaft upped their target price on shares of Astera Labs from $60.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, November 5th. One equities research analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Astera Labs has a consensus rating of “Buy” and a consensus target price of $115.33.

Check Out Our Latest Stock Report on ALAB

Astera Labs Price Performance

NASDAQ ALAB opened at $87.50 on Thursday. Astera Labs has a 52-week low of $36.22 and a 52-week high of $147.39. The firm has a 50-day moving average price of $121.35 and a 200 day moving average price of $82.90.

Insider Activity at Astera Labs

In other Astera Labs news, Director Stefan A. Dyckerhoff sold 197,297 shares of the stock in a transaction on Monday, November 18th. The stock was sold at an average price of $90.51, for a total transaction of $17,857,351.47. Following the transaction, the director now owns 6,148 shares of the company’s stock, valued at $556,455.48. This represents a 96.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director Manuel Alba sold 11,000 shares of Astera Labs stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $117.50, for a total value of $1,292,500.00. Following the completion of the sale, the director now directly owns 456,863 shares of the company’s stock, valued at approximately $53,681,402.50. This represents a 2.35 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 846,452 shares of company stock valued at $86,427,256 over the last quarter.

Institutional Investors Weigh In On Astera Labs

A number of institutional investors have recently bought and sold shares of the stock. Tidal Investments LLC grew its stake in shares of Astera Labs by 81.8% during the 3rd quarter. Tidal Investments LLC now owns 45,298 shares of the company’s stock valued at $2,373,000 after buying an additional 20,388 shares during the period. Point72 Asia Singapore Pte. Ltd. acquired a new position in Astera Labs in the third quarter valued at $530,000. Avior Wealth Management LLC purchased a new stake in Astera Labs during the third quarter valued at about $361,000. Maverick Capital Ltd. increased its stake in Astera Labs by 16.0% during the third quarter. Maverick Capital Ltd. now owns 1,156,230 shares of the company’s stock worth $60,575,000 after acquiring an additional 159,480 shares during the last quarter. Finally, Bank of Hawaii acquired a new position in shares of Astera Labs in the 3rd quarter valued at about $1,409,000. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Astera Labs Company Profile

(Get Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Read More

Earnings History and Estimates for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.